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Abstract
Our objective was to explore the social meaning of HIV and perceptions of an HIV cure among people who
inject drugs (PWID) in Guangzhou, China, which speaks to ethical and resource challenges to development in
this field. We conducted a qualitative research study using in-depth interviews. We analyzed interview tran-
scripts from 29 PWID, eight physicians, and three social workers from an outpatient HIV clinic and two
methadone maintenance treatment centers. The social meaning of HIV infection and perceptions of an HIV cure
reflected patients’ relationships with society, health systems, and physicians. First, HIV infection decreased
perceived social worth and disrupted peer relationships. The possibility of being cured renewed patient hope for
regaining physical well-being and achieving social mobility. However, the existence of a cure may not alter the
HIV-related stigma due to its association with stigmatized behaviors and marginalized groups. Second, although
stigma was a significant barrier to engagement in health care, hope for a cure may outweigh fears of stigma and
enhance linkage to HIV testing and treatment as well as methadone services. A cure may exacerbate perceived
health disparities if inaccessible to key affected populations such as PWID. The social implications of an HIV
cure among this key affected population may inform the design and implementation of cure clinical trials.
Careful management of patient expectations, focusing research on key affected populations, expanding HIV
testing and treatment systems, improving access to harm reduction programs, and ensuring post-trial access are
important considerations for HIV cure research.
Introduction
In the past three decades, the meaning of HIV as anillness has evolved significantly for patients: from facing
imminent mortality, to enduring toxic treatment regimens, to
now the long-term task of managing a chronic disease and
preventing acute complications.1 Recent cases of HIV-
infected individuals who are healthy off antiretroviral treat-
ment (ART)2,3 have accelerated research efforts toward a
generalizable cure.4 The potential transition of HIV from an
incurable to curable disease may bring substantial changes to
health systems and have unique social and ethical implica-
tions.5 After all, HIV is as much a profound social issue as a
medical one, disrupting social relationships and dispropor-
tionately affecting marginalized populations.6 Early clinical
trials are studying treatment during acute infection, gene
modification to confer innate resistance to HIV, administra-
tion of neutralizing antibodies, and therapeutic vaccines.4
However, these experiments are limited to proof-of-concept
studies bridging animal and human research in order to de-
velop tools and methods for future clinical trials and have no
clinical benefit for participants.5
In this study, we focused on people who inject drugs
(PWID) in Guangzhou, China, a key affected population that
bears a significant burden of HIV. There are approximately
1.16 million drug users in China and 6.4% are HIV infected,
compared to 0.03% in the general population.7–9 The risk
environment theory argues that people who inject drugs are
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susceptible to structural and environmental factors that
increase their risk for both substance abuse and other health-
related harms, including HIV infection.10–12 China, in par-
ticular, has the largest population of drug users in the world,
and injection drug use accounts for 20% of all new HIV
infections.9,13 Furthermore, PWID traditionally have very
low rates of linkage to HIV care and may face some of the
largest barriers to accessing a potential HIV cure.14,15 Fo-
cusing on PWID was an opportunity to examine relationships
between individuals, physicians, health systems, and society.
China is experiencing a rapidly evolving health policy
environment with growing political support for harm reduc-
tion and scale-up of HIV prevention, testing, and treatment
efforts.16,17 The emergence of national ‘‘champions’’ en-
couraged a culture of pragmatic, evidence-based practice that
has spurred collaboration across public health, police, and
drug sectors.16,17 However, HIV continues to hold a powerful
cultural meaning in China as the modern-day plague.18 Fear
of infection and death are magnified by its association with
stigmatized behaviors,19 which continue to hinder progress in
HIV care. A complex social environment, coupled with rapid
change in health policy, provide a unique opportunity to ex-
amine social relationships that may be affected by an HIV cure.
Qualitative research has helped define social and structural
factors of the HIV epidemic,20 influence program im-
plementation,21 and enrich quantitative studies.22 Under-
standing the impact of an HIV cure is fundamentally about
the meaning of HIV in people’s lives and what might happen
when an individual no longer has HIV. Few qualitative
studies conducted in China are available in the English lit-
erature. We undertook this qualitative research to charac-
terize social implications of curing HIV in HIV-infected
PWID in Guangzhou, China, and to gain insight into the
social context of HIV cure clinical studies.
Materials and Methods
Site
We selected Guangzhou, China, for our study due to the
location of a well-established HIV treatment clinic, the
Guangzhou Eighth People’s Hospital, and a centralized
methadone maintenance treatment system. Our study site was
uniquely positioned to examine the risk environment of HIV-
infected PWID. Field observation took place for one month
prior to interviews.
Subject recruitment
A purposive sample of HIV-infected PWID was recruited
from the Guangzhou Eighth People’s Hospital and two district-
based methadone clinics from October 2013 to March 2014.
Physicians and social workers were interviewed to provide
additional perspective and corroborate patient perceptions.
Verbal consent was obtained from all participants. All partici-
pants received a phone card worth 100 RMB (approximately 16
USD) for their participation. All participants were told that
there were no ongoing HIV cure trials in China and were en-
couraged to adhere to recommended ART regimens.
Interviews
A semistructured, in-depth interview guide (Supplement
1) was field tested among eight patients, two inpatient phy-
sicians, and three community leaders. Trained interviewers
fluent in the local language (Cantonese or Mandarin) con-
ducted interviews in a private location. The interview dura-
tion was 30 to 120 minutes. Interviews were audio recorded if
consent was given; if not, field notes were taken. The inter-
view topic guide elicited patients’ narratives on their medical
care, personal relationships, injection drug use including
methadone treatment, as well as their expectations and per-
ceptions of a potential HIV cure. Given the rapidly evolving
field of HIV cure research, we did not attempt to describe
specific cure modalities but asked generally about the theo-
retical impact of an HIV cure on patients’ lives. We defined
‘‘cure’’ in the following ways: as an intervention (‘‘the
cure’’), a state of being (‘‘being cured’’), and modifying
perceptions of HIV (‘‘if HIV became curable’’). Care was
taken to ensure that patients understood that there was no
HIV cure yet and that they should continue to adhere to
current medical recommendations. Emergent themes were
explored further in subsequent interviews until thematic
saturation was reached.
Analysis
Our methodological approach was based in grounded
theory.23 Interview transcripts were the sources of primary
data. Transcripts were translated from Chinese to English and
then analyzed using Atlas.ti software (Version 7, Atlas.ti
Scientific Software Development GmbH, Berlin, Germany).
Transcripts were coded independently and coding dis-
crepancies were discussed to achieve consistency and reli-
ability of interpretation (Supplement 2).
The UNC Chapel Hill Institutional Review Board (IRB)
and Guangzhou Eighth People’s Hospital IRB approved this
study. IRB approval from UCSF was deferred to UNC Chapel
Hill.
Results
Interview data were analyzed from 29 patients, eight
physicians, and three social workers (Table 1). The social
effects of HIV infection and perception of HIV cure are
presented in the context of three key relationships: patient–
society, patient–health system, and patient–physician
(Table 2).
Patients’ relationships with society
Effects of HIV. HIV infection resulted in isolation, de-
creased self-worth, and decreased social status. Patients felt
inferior or ‘‘spoiled’’ for being HIV infected. As a result,
patients disassociated with HIV-negative friends, and social
networks narrowed. Patients traveled long distances away
from their hometowns to work and seek medical care out of
fear of disclosure.
‘‘Right now it is like I have drawn a circle around myself.’’
– Patient, 50 M
‘‘I have become used to living alone for the past twenty,
thirty years.I think I am a little inferior, that’s my feeling.’’
– Patient, 47 M
Patients established new peer groups based on an HIV or
PWID identity. Over time, some patients found new peer
groups among other HIV-infected patients or PWID. Settings
for peer support included methadone clinics (often facilitated
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by social workers), the HIV outpatient clinic, church-sponsored
drug rehabilitation groups, or online forums. Peer relation-
ships were important for disseminating information about
treatment and news of cure.
A patient described how a former injection drug user,
whom he met in a drug detention center, has become a crucial
source of social support:
‘‘My friend has always been an elder brother I admire.
When I feel reluctant to move forward, he would come to
help me.’’ – Patient, 41 M
Finding peers allowed the patient to find mutual respect,
understanding, and a sense of normalcy.
‘‘In my circle, there is no such thing as shame. We are
similar to each other and lead our lives like normal people.’’
– Patient, 51 M
Peer relationships helped patients establish a new sense of
belonging in the face of feelings of inferiority.
‘‘We tend to make friends with those who are also AIDS
patients. I am a drug addict, so were all my friends.To be
honest, I think I am an ‘inferior’ in society, so are my friends.
We are low level people.’’ – Patient, 50 M
Other factors associated with perceived low social status
included unemployment, low education background, and
poor physical health. These factors contributed to a pervasive
sense of fatalism within this peer group.
‘‘All I hope for is that the people around me don’t look
down upon me, so that I will hold an accepting attitude to-
wards my death.’’ – Patient, 40 M
PWID relied on family for HIV care and protection against
stigma. Families provided emotional and mental support for
patients to ensure regular follow-up care, substance abuse
recovery, medication adherence, and healthy habits. In many
cases, immediate family members (parents and siblings) were
the only people to whom the patients disclosed their HIV
status. The family was seen as the locus of responsibility
rather than the individual. Parents were sources of financial
support during hospitalizations and outside of the hospital.
Parental support was also protective against social stigma and
maintaining social unity.
‘‘If not even your family will support you, your life is
meaningless, outside people will discriminate against you
even more’’ – Patient, 39 M
Table 2. Meaning of HIV Infection and Perception of an HIV Cure
Meaning of HIV infection Perception of HIV cure
Patient–society PWID view themselves as inferiors or
social outcasts.
Family and peer groups are protective
against stigma and central to HIV care
including medication adherence and
emotional well-being.
New peer support groups are established
based on HIV or drug use, forming a
new collective identity.
The possibility of being cured of HIV
inspires hope among PWID with the
possibility of reintegration into society.
The curability of HIV would decrease
fatalistic attitudes toward the disease
and may reduce fear and stigma.
Curing HIV may not change a patient’s
identity as a formerly HIV-infected
individual.
Patient–health system HIV is an important national health
priority with free comprehensive care
and treatment for those who seek it.
Many HIV-infected PWID remain
outside of care due to stigma and other
barriers.
Methadone is an important point of entry
to care for PWID.
Increased testing uptake and linkage to
care may be a positive unintended
consequence of cure research.
PWID believe they will not have access to
a cure even if it were available due to
financial and other structural barriers.
Patient–physician HIV specialist physicians establish
relationships with their patients in a
primary care-like model.
Long-term physician–patient
relationships increase trust and
adherence. However, HIV-associated
stigma is prevalent.
HIV cure may be a less desirable
intervention when compared to ART,
which is free, low risk, and highly
effective.
Table 1. HIV-Infected People Who Inject
Drugs in Guangzhou, China: Sociodemographic
Characteristics
Age (years) 27–53
Gender 28 male, 1 female
Currently in methadone treatment 12 (41%)
Guangzhou urban residenta 17 (59%)
Highest education level completed Elementary: 9 (31%)
Middle: 13 (45%)
High school: 6 (21%)
College: 1 (3%)




Average income (USD/year) 3,150
History of detentionb 76%









aChina requires a household registration system (hukou) to
maintain an accurate census and differentiate between urban and
rural status.
bPeople who inject drugs (PWID) are routinely arrested and
detained at compulsory detoxification centers for months to years.
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Perception of HIV cure. Curing HIV may motivate pa-
tients to reenter society. Some patients felt that a cure for HIV
would help them regain normalcy. The thought of being
cured increased their hope for marriage, having children,
finding employment, and regaining social mobility.
‘‘Right now, I can’t even imagine having my own child. If I
could be cured, I can think about having a baby. Otherwise, if
I die, who will take care of my kid? So if I could be cured,
everything would be different.’’ – Patient, 42 M
Curing HIV may not alter perceptions of the disease. Even
if HIV were curable, social judgment directed against the
behaviors associated with HIV transmission would remain.
‘‘Even if this disease will be curable, getting this disease
will never become a good thing.’’ – Patient, 42 M
‘‘If you said I would see cured patients as normal people, I
think that is very unlikely, I would always feel a little cau-
tion.’’ – Patient, 39 M
Curing HIV was related to syphilis, which is curable with
penicillin but continues to engender prejudice as a sexually
transmitted infection. Whereas social workers were likely to
state that curing HIV could increase hope and self-efficacy,
physicians were more likely to view an HIV cure in the
context of other infectious diseases that have cures, but re-
main prevalent and stigmatized.
‘‘It is like if someone has syphilis, would you act as if
nothing happened? Syphilis can be cured.’’ – Physician,
41 M
Patients felt that curing HIV would not be enough to dis-
sociate them from their HIV-positive identity and anticipated
difficulty convincing others that they were cured.
‘‘If people discriminate against you, it is the same if you
are cured or not cured, because you had the disease before,
right? For example, you had the disease, you tell someone
that your disease is cured. Will the other people believe it? It
is the same to me, to be cured or not. This thing is invisible.’’
– Patient, 37 M
Patients’ interactions with health systems
Effects of HIV. HIV strengthened the healthcare infra-
structure. Patients were aware that they were eligible for free,
first-line ART, free methadone, and access to HIV-specific
subsidies and supplemental insurance. Methadone was an
important point of entry to care for PWID, where HIV testing
took place, and social workers facilitated referral to HIV
specialists and other resources. Despite these policies, pa-
tients and social workers also felt strongly that most HIV-
infected PWID remain outside of care due to stigma, fear of
disclosure, and ancillary costs of care including transporta-
tion and diagnostic tests.
Perception of HIV cure. An HIV cure would increase
hope and linkage to care. Patients, physicians, and social
workers believed that a cure would motivate currently un-
treated HIV-positive PWID to be tested sooner and seek care,
before the development of symptomatic opportunistic ill-
nesses requiring hospitalization (78% of our subjects were
hospitalized at least once for an AIDS-defining condition).
The perception of HIV as a curable disease could inherently
alter fatalistic attitudes toward the disease.
‘‘If HIV could be cured, there would be great hope for life.
[PWID] will have more motivation to get treated or tested, or
even motivate others to get tested and treated. Many patients
refuse treatment because of their assumptions about HIV.
They think that HIV is incurable, and treatment is ineffective.
So they would rather maintain their quality of life and indulge
in drugs. In other words, if HIV could be cured, they would
adopt a more positive attitude and alter their behaviors.’’
– Social worker, 27 M
Some PWID avoided HIV testing and treatment for other
reasons, including fear of disclosure and stigma and be-
coming labeled as HIV positive. A fundamental shift of HIV
from incurable to curable could normalize the disease, in-
creasing hope and motivation for patients to address both
HIV and substance abuse issues.
‘‘If it can be cured.it is the same as getting a cold. You
can cure it completely, so there is no discrimination anymore.
The main problem is that it is incurable.’’ – Patient, 39 M
In contrast, the greatest perceived barrier was financial,
and hopefulness toward a cure was tempered by personal
poverty.
‘‘If you have money, you can have hope. People like me
don’t.new medicines that come to China will always cost us
money. I won’t be able to afford it, so I don’t have much
hope.’’ – Patient, 40 M
Behavioral disinhibition with an HIV cure is uncertain. On
the one hand, patients did not believe that drug use would
become a less harmful practice even if HIV were curable,
citing financial and social consequences as primary deter-
rents. There was little awareness of drug use as a high-risk
behavior for HIV transmission.
‘‘Drug use is drug use, while HIV is HIV, they are not
equal. Not every drug user has HIV.’’ – Patient, 38 M
On the other hand, physicians expected to see some
increase in risk behaviors if HIV could be cured, drawing
parallels with the increasing incidence of sexually trans-
mitted infections despite the availability of effective an-
tibiotics.
Patients’ relationships with physicians
Effects of HIV. HIV specialist physicians established
primary care relationships with patients. Management of HIV
as a chronic disease facilitated continuity of care, with regular
follow-up. This facilitated long-term patient relationships in
the setting of perceived widespread stigma within the medical
community. As a result, the HIV specialist functionally be-
came a primary provider and managed other medical con-
ditions. Physicians were also gatekeepers to specialists and
social services for HIV-infected PWID.
Long-term physician–patient relationships increased trust.
Across clinic settings, physicians were seen as a source of
authority and expertise. Patients reciprocated with respect,
acceptance of medical recommendations, and high levels of
trust.
‘‘I don’t know if treatment will work, but if the doctor told
me I should be treated, I will obey. My thought is, I’m not sure
of the medical outcome, but I have faith in my doctors’
opinions.’’ – Patient, 39 M
Physicians also believed that providing hope for patients
was important in maintaining a therapeutic relationship. This
‘‘healer’s relationship’’ promoted medication adherence,
abstinence from substance abuse, attendance at follow-up
visits, and a positive outlook about HIV. It was a means of
communicating trusted information and managing expecta-
tions for HIV.
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HIV-associated stigma by medical professionals was prev-
alent. Many patients experienced refusal of care by medical
providers due to their HIV status. This delayed initiation of
ART and other necessary interventions.
‘‘When the doctors found out I had HIV, they refused my
surgery.they said they would have to throw all their
equipment away.’’ – Patient, 47 M
Fear of infection and lack of understanding about HIV
were the main contributors to stigma.
Perception of HIV cure. Early HIV cure research may be
a less desirable intervention when compared to ART. Phy-
sicians believed that a cure might not be necessary for many
of their patients because of the demonstrated success of free
ART in controlling HIV. Some physicians had already de-
scribed ART in terms of ‘‘cure’’ (zhihao) as motivation for
medication adherence to achieve undetectable viral loads.
Physicians were concerned that HIV cure research should not
overshadow the importance of increasing access to ART
regimens. They were also concerned that a cure available
only to a select group of patients may undermine trusting,
established relationships with patients.
Discussion
Understanding the social effects of an HIV cure will re-
quire us to combine the science of treating disease with the
art of healing illness, the latter of which requires careful
attention to psychosocial aspects of care and awareness
of the social conditions of HIV infection.24 In this focused
study of HIV-positive PWID in Guangzhou, China, we
describe an HIV illness narrative and investigate percep-
tions of an HIV cure among this key affected population.
Our results in each of three key domains (patient–society,
patient–health systems, and patient–physician) provide in-
sight into the design and implementation of HIV cure
clinical trials (Table 3).
This study is part of a larger multiinstitutional, multidis-
ciplinary research effort to investigate the biosocial impli-
cations of curing HIV infection in order to develop a
theoretical framework about HIV cure research and early
implementation, to determine HIV cure stakeholder per-
spectives, and to develop an online forum to promote stake-
holder engagement.5 Our empirical data represent a biosocial
approach to understanding HIV and will inform future re-
search questions for formal stakeholder analysis and com-
munity engagement.
Community support from family, friends, and peer groups
was an important coping mechanism for patients living with
HIV. This is consistent with the existing literature on the
positive impact of social support for HIV-infected individu-
als.25–27 Other studies in both Western and non-Western
contexts have shown that social support is protective against
stigma, can increase physical and mental resilience, and can
improve medication adherence and other health-related be-
haviors.28,29 This supports the need to provide comprehen-
sive psychosocial support for patients and to engage families
and peer networks in HIV cure research trials.
Hope was a dominant theme that emerged in our discus-
sions of HIV cure, particularly in healthcare settings. Health
workers (physicians and nurses) were some of the most im-
portant ‘‘others’’ in patients’ lives and were seen as key
sources of support, strength, and hope in the face of persistent
stigma. Hope has been described as important for resilience,
community building, and overall health outcomes.1 How-
ever, hope may also lead to the dangers of therapeutic mis-
conception, a failure to distinguish between research and
clinical treatment.30 Failure to manage expectations in early
preexposure prophylaxis studies led to mistrust and prema-
ture termination of clinical trials.31 Supporting the formation
of honest and mutually accountable relationships among
patients, physicians, social workers, and other medical pro-
fessionals may mitigate some of the risks of HIV cure re-
search.
Table 3. Implications for HIV Cure Research Trials
Implications for HIV cure research trials
Patient–society Hope is a salient new theme in HIV cure research. Patient expectations should be
accurately assessed, particularly when the goal of research is common scientific
knowledge with minimal chance of individual benefit.
HIV research trials should identify, empower, and include key populations affected
by HIV who have not traditionally been enrolled in HIV research studies, such as
PWID.
Increasing capacity for psychosocial services, particularly in middle–income
countries, is critical in all stages of cure research and will strengthen existing
systems.
Patient–health system Local HIV testing, treatment, and harm reduction capacity should be scaled up in
anticipation of increasing numbers of HIV-positive patients seeking care.
Supporting methadone clinics and expanding harm reduction services may facilitate
engagement in care of PWID and enrollment in cure trials.
Discussion of posttrial access to cure and financial costs for key affected populations
should begin early and engage international stakeholders.
Patient–physician HIV-associated stigma within the medical profession should be systematically
addressed in settings where it is prevalent, with emphasis on maintaining
confidentiality to preserve physician–patient trust.
HIV specialists are important patient advocates and decision makers, particularly in
local settings without primary care-based health systems, and should be considered
key stakeholders in cure research and trial design.
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Our finding that an HIV cure may motivate testing and
linkage to care among PWID has important public health
implications. This finding is consistent with improvements in
testing rates that occurred after the development of other
cures for sexually transmitted diseases, such as penicillin and
salvarsan for syphilis.32 Qualitative research has suggested
that the incurability of HIV contributes to fatalism and low
HIV test uptake.33,34 However, HIV cure research may re-
frame the disease as potentially curable, promoting early
testing and linkage to care that could be synergistic with
ongoing treatment as prevention programs.35
HIV cure clinical research designs should consider both
post-trial access and conducting research among under-
represented, key affected populations such as PWID. Fi-
nancial concerns were already emerging as a barrier in a
health system in which patients are dependent on government
policies for free medication. An HIV cure was perceived as a
high-tech intervention that would be largely inaccessible to
low- and middle-income countries for a long time. This
perception implicates the history of access to antiretroviral
therapy both in China and other middle- and low-income
countries, which occurred in delayed, yet incremental ad-
vances.17 Unless existing health disparities are systematically
addressed, a cure may represent yet another unattainable
health intervention beyond patients’ reach and highlight ex-
isting social and structural barriers affecting PWID.
Conclusions
This qualitative study characterizes the social meaning of
HIV among PWID, a key affected population, in Guangzhou,
China, and investigates perceptions of an HIV cure in prep-
aration for cure clinical trials. By understanding the meaning
of HIV and the implications of a cure, we identify possible
opportunities and challenges for HIV clinical trial research
from the perspective of social and health systems. The pos-
sibility of curing HIV may bring hope, increase linkage to
care, and increase self-efficacy for PWID. However, existing
social and structural factors that define an individual’s risk
environment cannot be addressed by a biomedical cure alone.
Conducting cure research fundamentally shifts our approach
to HIV research by altering the perceptions and expectations
of key affected populations and other stakeholders. Con-
sidering the social aspects of cure research is an important
step in creating synergy with existing HIV treatment and
prevention programs. The long-term success and global im-
pact of HIV cure clinical trials will require understanding of
diverse social contexts.
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